CPG
GSK icon

Cornerstone Planning Group’s GSK GSK Stock Holding History

Cornerstone Planning Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Sell
289
-22
-7% -$1.16K ﹤0.01% 774
2026
Q1 		$15.7K Buy
311
+52
+20% +$2.82K ﹤0.01% 752
2025
Q4 		$13K Sell
259
-48
-16% -$2.24K ﹤0.01% 717
2025
Q3 		$14.4K Buy
307
+49
+19% +$1.91K ﹤0.01% 671
2025
Q2 		$9.64K Sell
258
-12
-4% -$459 ﹤0.01% 567
2025
Q1 		$10K Buy
270
+45
+20% +$1.65K ﹤0.01% 567
2024
Q4 		$7.97K Buy
225
+11
+5% +$396 ﹤0.01% 479
2024
Q3 		$8.18K Buy
214
+14
+7% +$573 ﹤0.01% 460
2024
Q2 		$7.88K Buy
200
+187
+1,438% +$7.87K ﹤0.01% 490
2024
Q1 		$566 Buy
13
+4
+44% +$165 ﹤0.01% 903
2023
Q4 		$334 Hold
9
– – ﹤0.01% 819
2023
Q3 		$326 Buy
+9
New +$319 ﹤0.01% 963

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Cornerstone Planning Group's GSK Position: Q2 2026 in Review

Cornerstone Planning Group reduced its GSK (GSK) stake by 7.1% in Q2 2026, selling an estimated $1.16K and leaving 289 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

Cornerstone Planning Group first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.7K in Q1 2026. 683 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cornerstone Planning Group held 289 shares of GSK worth $14.7K as of Q2 2026.
  • Cornerstone Planning Group sold 22 GSK shares in Q2 2026, an estimated $1.16K.
  • GSK made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #774 holding.
  • Cornerstone Planning Group first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
  • Cornerstone Planning Group's GSK position peaked at $15.7K in Q1 2026.
  • 683 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.